Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate to Prevent Progression of Non-proliferative Retinopathy in Diabetes
NCT03439345Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenofibrate in diabetic retinopathy (DR), sponsored by University of Oxford. Started Jul 2018; status: completed.
02
Drugs
fenofibrate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT03439345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439345.